ALVAC-CEA vaccine explained

ALVAC-CEA vaccine is a cancer vaccine containing a canary pox virus (ALVAC) combined with the carcinoembryonic antigen (CEA) human gene.[1]

A phase I trial in 118 patients showed safety in humans.[2]

External links

Notes and References

  1. Web site: NCI Drug Dictionary . Comprehensive Cancer Information . 2024-07-02.
  2. Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer. . Clinical Cancer Research . 2008. 14 . 15 . 4843–4849 . Kaufman . Howard L. . Lenz . Heinz-Josef . Marshall . John . Singh . Deepti . Garett . Chris . Cripps . Christine . Moore . Malcolm . von Mehren . Margaret . Dalfen . Richard . Heim . William J. . Conry . Robert M. . Urba . Walter J. . Benson . Al B. . Yu . Maria . Caterini . Judy . Kim-Schulze . Seunghee . Debenedette . Mark . Salha . Danielle . Vogel . Thorsten . Elias . Ileana . Berinstein . Neil L. . 10.1158/1078-0432.CCR-08-0276 . 18676757 . 18152383 . free .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "ALVAC-CEA vaccine".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.